Changes in adiponectin and leptin are known to promote overweight and obesity, and exacerbate insulin resistance in those individuals, lending further support to the notion that obesity and the consequent abnormal whole-body metabolism remains the single most important predictor of the risk of pre-eclampsia. Here, ADIPOQ is linked to Obesity.